Amgen Hammered As 'Tough' Obesity Meeting Reminds It It's Not The Incumbent

investors.com/news/technology/amgen-obesity-drug-maritide-eli-lilly-zepbound-branch

Amgen presented promising results for its weight-loss drug. But not everyone is convinced.
The post Amgen Hammered As 'Tough' Obesity Meeting Reminds It It's Not The Incumbent appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-23 18:30:00.
The Entire Business World on a Single Page. Free to Use →